Jasper Therapeutics

About:

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Website: https://jaspertherapeutics.com

Twitter/X: JasperBio

Top Investors: Samsara BioCapital, Amgen, Avidity Partners, Alexandria Venture Investments, Citadel

Description:

Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and gene therapies. The company s novel engineered hematopoietic stem cells (eHSCs) platform aims to overcome the limitations of transplant grafts while also unlocking the potential of stem cells, potentially increasing the number of patients who could benefit from allogeneic and autologous gene-edited hematopoietic stem cell therapy. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.